Cellebrite DI (CLBT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Cellebrite DI (CLBT) is Neutral.

The composite score behind that read is -0.15, weighing +0.17 of bullish evidence against -0.27 bearish.

Cellebrite DI last closed at $11.20, +1.17% on the session.

Against the IVW growth benchmark the position is +0.25% over the forecast window.

The read is built from 11 underlying insights — 3 bullish and 8 bearish.

Agreement across those insights is 73%.

1 graded prediction for CLBT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Cellebrite DI in the 14th percentile on valuation and the 65th percentile on return on equity, where 100 is best.

Cellebrite DI is classified under Information Technology / Software, with a market capitalisation of $2.78B.

StockMap tracks Cellebrite DI as the 87th largest of the 183 companies it covers in the Software industry, part of the Information Technology sector.

Across that group the current two-week reads are 135 Neutral, 41 Moderate Underperform, 6 Moderate Outperform and 1 Strong Underperform.

On that composite Cellebrite DI ranks 120th of 183 in the group, against a group median of -0.08.